184 related articles for article (PubMed ID: 9674759)
1. Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation.
Geula C
Neurology; 1998 Jul; 51(1 Suppl 1):S18-29; discussion S65-7. PubMed ID: 9674759
[TBL] [Abstract][Full Text] [Related]
2. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
3. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.
Geula C; Mesulam MM
Cereb Cortex; 1996; 6(2):165-77. PubMed ID: 8670647
[TBL] [Abstract][Full Text] [Related]
4. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG; Svendsen CN; Selkoe DJ
Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
[TBL] [Abstract][Full Text] [Related]
6. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?
Mesulam M
Learn Mem; 2004; 11(1):43-9. PubMed ID: 14747516
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia.
Dringenberg HC
Behav Brain Res; 2000 Nov; 115(2):235-49. PubMed ID: 11000423
[TBL] [Abstract][Full Text] [Related]
8. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
Schliebs R; Arendt T
J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
[TBL] [Abstract][Full Text] [Related]
9. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
10. The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings.
Frölich L
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1003-13. PubMed ID: 12111437
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: a disorder of cortical cholinergic innervation.
Coyle JT; Price DL; DeLong MR
Science; 1983 Mar; 219(4589):1184-90. PubMed ID: 6338589
[TBL] [Abstract][Full Text] [Related]
13. Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease?
Fukui T; Hieda S; Bocti C
Dement Geriatr Cogn Disord; 2006; 22(5-6):421-31. PubMed ID: 16974095
[TBL] [Abstract][Full Text] [Related]
14. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
15. Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.
Martinez JL; Zammit MD; West NR; Christian BT; Bhattacharyya A
Front Aging Neurosci; 2021; 13():703876. PubMed ID: 34322015
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.
Orta-Salazar E; Cuellar-Lemus CA; Díaz-Cintra S; Feria-Velasco AI
Neurologia; 2014 Oct; 29(8):497-503. PubMed ID: 23433740
[TBL] [Abstract][Full Text] [Related]
18. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenetic factors of Alzheimer disease].
Bauer J; Hüll M; Berger M
Z Gerontol Geriatr; 1995; 28(3):155. PubMed ID: 7664189
[TBL] [Abstract][Full Text] [Related]
20. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease.
von Gunten A; Bouras C; Kövari E; Giannakopoulos P; Hof PR
Brain Res Rev; 2006 Aug; 51(2):176-211. PubMed ID: 16413610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
